Protagenic Therapeutics Inc (STU:MBP)
€ 0.595 0.065 (12.26%) Market Cap: 2.50 Mil Enterprise Value: -1.96 Mil PE Ratio: 0 PB Ratio: 3.60 GF Score: 33/100

Protagenic Therapeutics Inc Annual Shareholders Meeting Transcript

Nov 23, 2022 / 03:00PM GMT
Release Date Price: €1.98 (-7.12%)
Garo Armen
Protagenic Therapeutics, Inc. - Executive Chairman

Good day, everyone. I'd like to call to order Protagenic Therapeutics' Annual Meeting of Stockholders. Participating in the meeting today are our Board members, Khalil Barrage, Josh Silverman, Bob Stein, Brian Corvese, and Jennifer Buell.

I'd like to thank them and each one of you for your time and commitment to Protagenic Therapeutics. I'd also like to offer a special thanks to Josh Silverman for his almost seven years of service on our Board of Directors. As of today, he is rotating off the Board while we welcome our new director, Tim Wright, who will be taking his place.

Now I'd like to introduce you to Alexander Arrow, the company's Chief Financial Officer and Corporate Secretary, to conduct the formal portion of our meeting. After the completion of the formal portion, I'll come back and give you a brief update on the company's progress and future outlook. Alex?

Alexander Arrow
Protagenic Therapeutics, Inc. - CFO

Thank you, Garo. This meeting was called by the Board of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot